Clinical Trial: A Study Comparing DMSB01 and Rejuran(R) for Temporary Crow's Feet Lines Improvement

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06402058) titled 'A Study Comparing DMSB01 and Rejuran(R) for Temporary Crow's Feet Lines Improvement' on May 2.

Brief Summary: The objective of this Pilot Study is to verify the safety and efficacy of DMSB01 in the temporary improvement of Crow's Feet Lines

Study Type: Interventional

Condition: Crow's Feet Lines

Intervention: * Device: DMSB01

Apply a maximum of 1.0 ml for each side of the Crow's Feet Lines using both the test device (DMSB01) and the control device (Rejuran(R)).

* Device: Rejuran(R)

Apply a maximum of 1.0 ml for each side of the Crow's Feet Lines using both the test device (DMSB01) and the control device (Rejuran(R)).

Recruitmen...